Suppression of HIV antigenaemia by AL721.
Shinitzky
M
M
Skornick
Y
Y
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000998:Antiviral Agents / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D005989:Glycerides / Q000627:therapeutic use*; D015488:HIV Antigens / Q000032:analysis*; D006801:Humans; D010713:Phosphatidylcholines / Q000627:therapeutic use*; D010714:Phosphatidylethanolamines / Q000627:therapeutic use*; D015215:Zidovudine / Q000627:therapeutic use
D000998:Antiviral Agents; D004338:Drug Combinations; D005989:Glycerides; D015488:HIV Antigens; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D015215:Zidovudine; C046637:neutral lipid, phosphatidylcholine, phosphatidylethanolamine drug combination